| |
| |
|
| Insider
Information: |
Langer Robert |
| Relationship: |
Director |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
23,176,520 |
|
|
Indirect Shares
|
68,091 |
|
|
| Direct
Value |
$54,894,728 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,244,611 |
|
|
| Total
Value |
$54,894,728 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2008-08-08 |
950,022 |
|
0 |
Premium* |
|
|
Echo Therapeutics Inc |
ECTE |
Director |
2009-12-11 |
603,450 |
2004-05-26 |
0 |
Premium* |
|
|
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2013-06-05 |
7,433,628 |
|
0 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-26 |
738,424 |
|
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
10% Owner |
2016-06-21 |
457,603 |
|
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-19 |
326,402 |
|
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
Director |
2022-04-28 |
11,467,664 |
2022-04-28 |
42,396 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2019-10-14 |
0 |
2019-01-14 |
0 |
Premium* |
|
|
Korro Bio |
KRRO |
Director |
2020-11-17 |
214,326 |
2020-11-17 |
25,695 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director |
2020-05-05 |
15,167 |
|
0 |
Premium* |
|
|
Sqz Biotechnologies Co |
SQZ |
10% Owner |
2020-10-29 |
243,987 |
|
0 |
Premium* |
|
|
Seer, Inc. |
SEER |
Director |
2023-06-14 |
725,847 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SEER |
Seer, Inc. |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,443 |
725,847 |
0 |
- |
|
| SEER |
Seer, Inc. |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,945 |
702,404 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Director |
• • – |
2022-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
703 |
11,467,664 |
0 |
- |
|
| SEER |
Seer, Inc. |
Director |
– • – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
327,102 |
692,459 |
0 |
- |
|
| SEER |
Seer, Inc. |
Director |
– • – |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
205,831 |
365,357 |
0 |
- |
|
| SEER |
Seer, Inc. |
Director |
– • – |
2020-12-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
159,526 |
|
- |
|
| KRRO |
Korro Bio |
Director |
• • – |
2020-11-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
56,912 |
214,326 |
0 |
- |
|
| SQZ |
Sqz Biotechnologies Co |
10% Owner |
– – • |
2020-10-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
243,987 |
|
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
668 |
15,167 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2020-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,499 |
|
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-10-14 |
4 |
AS |
$8.52 |
$63,875 |
D/D |
(7,500) |
0 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-10-14 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| KRRO |
Korro Bio |
Director |
– • – |
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
271,238 |
|
- |
|
| KRRO |
Korro Bio |
Director |
– • – |
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,695 |
|
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-07-15 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-07-15 |
4 |
AS |
$14.94 |
$112,049 |
D/D |
(7,500) |
0 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-04-15 |
4 |
AS |
$17.57 |
$131,799 |
D/D |
(7,500) |
0 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-04-15 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-01-14 |
4 |
AS |
$14.59 |
$109,444 |
D/D |
(7,500) |
0 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2019-01-14 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Director |
– • – |
2018-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,559 |
11,466,961 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Director |
– • • |
2017-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
326,402 |
|
- |
|
| BIND |
DNIB Upwind Inc |
Director |
– • – |
2016-08-26 |
4 |
OE |
$0.44 |
$6,600 |
D/D |
15,000 |
738,424 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
10% Owner |
– – • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
457,603 |
|
- |
|
| BIND |
DNIB Upwind Inc |
Director |
– • – |
2013-09-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
723,424 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
